Reviewing the latest research on value-based care, clinical pathways, and precision medicine
Patient-Provider Discussions About Cancer Treatment Costs Decrease Out-of-Pocket Spending
Patient-provider discussions about treatment costs is associated with lower out-of-pocket costs while maintaining the quality cancer care, according to a recent study.
Read More
Health Care Spending for High-Resource Patients With Prostate Cancer
Study findings show 5% of men diagnosed with prostate cancer accounted for 26% of the total cost of care for all men diagnosed in 2009.
Read More
Avapritinib Adoption for GIST Demonstrates Minimal Budget Impact on US Health Plan
Study results suggest the budget impact of adopting avapritinib as a treatment option for metastatic or unresectable GIST is minimal.
Read More
FDA Approves Fam-Trastuzumab Deruxtecan-nxki for Gastric Cancer
The FDA granted approval to fam-trastuzumab deruxtecan-nxki for adults with locally advanced or metastatic HER2-positive gastric or gastroesophageal adenocarcinoma.
Read More
Using ASCO Value Framework to Compare Treatment Options for HCC
Application of ASCO value framework to compare the efficacy of treatment options for HCC found higher scores among FDA-approved therapies than those that were not.
Read More
Real-World Practice Patterns, Comorbidities in Medicare Patients With MCL
Older patients with MCL have a high rate of comorbidities impacting treatment choices and OS.
